Literature DB >> 26999468

Haematopoietic cell transplants in Latin America.

R P Gale1, A Seber2, C Bonfim3, M Pasquini4.   

Abstract

Haematopoietic cell transplants are done by more than 1500 transplant centres in 75 countries, mostly for life-threatening haematological disorders. However, transplant technology and access are not uniformly distributed worldwide. Most transplants are done predominately in Europe, North America and some Asian countries. We review transplant activity in Latin America, a geographic region with a population of >600 million persons living in countries with diverse economic and social development levels. These data indicate a 20-40-fold lower frequency of transplants in Latin America compared with Europe and North America. We show that although economics, infrastructure and expertise are important limitations, other variables also operate. Changes in several of these variables may substantially increase transplant activity in Latin America.

Entities:  

Mesh:

Year:  2016        PMID: 26999468      PMCID: PMC4935585          DOI: 10.1038/bmt.2016.35

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

Review 1.  Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center.

Authors:  Clarisse Martins Machado; Talita Chaves Martins; Iago Colturato; Marília Souza Leite; Anderson João Simione; Mair Pedro de Souza; Marcos Augusto Mauad; Vergílio Rensi Colturato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Oct-Dec       Impact factor: 1.846

2.  Transplanted technology: Third World options and First World science.

Authors:  S Woolhandler; D U Himmelstein; B Labar; S Lang
Journal:  N Engl J Med       Date:  1987-08-20       Impact factor: 91.245

3.  Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico.

Authors:  José Carlos Jaime-Pérez; Alberto Carlos Heredia-Salazar; Olga G Cantú-Rodríguez; Homero Gutiérrez-Aguirre; César Daniel Villarreal-Villarreal; Consuelo Mancías-Guerra; José Luís Herrera-Garza; David Gómez-Almaguer
Journal:  Oncologist       Date:  2015-03-06

4.  A Mexican way to cope with stem cell grafting.

Authors:  Guillermo J Ruiz-Delgado; Guillermo J Ruiz-Argüelles
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

5.  Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID).

Authors:  A Condino-Neto; R U Sorensen; A C Gómez Raccio; A King; F J Espinosa-Rosales; J L Franco
Journal:  Allergol Immunopathol (Madr)       Date:  2014-10-05       Impact factor: 1.667

6.  Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.

Authors:  M Nucci; M Garnica; A B Gloria; D S Lehugeur; V C H Dias; L C Palma; P Cappellano; K Y Fertrin; F Carlesse; B Simões; M D Bergamasco; C A Cunha; A Seber; M P D Ribeiro; F Queiroz-Telles; M L M Lee; M L Chauffaille; L Silla; C A de Souza; A L Colombo
Journal:  Clin Microbiol Infect       Date:  2012-09-25       Impact factor: 8.067

7.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

8.  Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion.

Authors:  Oscar González-Llano; Laura Nelly Rodríguez-Romo; María del Consuelo Mancías-Guerra; Luz Tarín-Arzaga; José Carlos Jaime-Pérez; José Luis Herrera-Garza; Olga Graciela Cantú-Rodríguez; César Homero Gutiérrez-Aguirre; Ricardo Daniel García-Sepúlveda; Ana Yuritzen García-Marín; Laura Villarreal-Martínez; María del Rosario Salazar-Riojas; David Gómez-Almaguer
Journal:  Hematology       Date:  2013-11-25       Impact factor: 2.269

9.  Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Authors:  G J Ruiz-Argüelles; L C Tarin-Arzaga; M L Gonzalez-Carrillo; K I Gutierrez-Riveroll; R Rangel-Malo; C H Gutiérrez-Aguirre; O G Cantú-Rodríguez; D Gómez-Almaguer; S Giralt
Journal:  Bone Marrow Transplant       Date:  2008-07       Impact factor: 5.483

10.  Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?

Authors:  Cesar Homero Gutiérrez-Aguirre; Andrés Gómez-De-León; Julio Alatorre-Ricardo; Olga Graciela Cantú-Rodríguez; Oscar González-Llano; José Carlos Jaime-Pérez; Consuelo Mancías-Guerra; Juan Antonio Flores-Jiménez; David Gómez-Almaguer
Journal:  Transfusion       Date:  2013-10-28       Impact factor: 3.157

View more
  5 in total

Review 1.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

Review 2.  Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.

Authors:  Ibrahim N Muhsen; Shahrukh K Hashmi; Dietger Niederwieser; Nicolaus Kroeger; Samir Agrawal; Marcelo C Pasquini; Yoshiko Atsuta; Karen K Ballen; Adriana Seber; Wael Saber; Mohamed A Kharfan-Dabaja; Walid Rasheed; Shinichiro Okamoto; Nandita Khera; William A Wood; Mickey B C Koh; Hildegard Greinix; Yoshihisa Kodera; Jeff Szer; Mary M Horowitz; Daniel Weisdorf; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2019-09-04       Impact factor: 5.483

3.  Transplantation of Hematopoietic Stem Cells for Primary Immunodeficiencies in Brazil: Challenges in Treating Rare Diseases in Developing Countries.

Authors:  Juliana Folloni Fernandes; Samantha Nichele; Liane E Daudt; Rita B Tavares; Adriana Seber; Fábio R Kerbauy; Adriana Koliski; Gisele Loth; Ana K Vieira; Luiz G Darrigo-Junior; Vanderson Rocha; Alessandra A Gomes; Vergílio Colturato; Luiz F Mantovani; Andreza F Ribeiro; Lisandro L Ribeiro; Cilmara Kuwahara; Ana L M Rodrigues; Victor G Zecchin; Beatriz T Costa-Carvalho; Magda Carneiro-Sampaio; Antonio Condino-Neto; Anders Fasth; Andrew Gennery; Ricardo Pasquini; Nelson Hamerschlak; Carmem Bonfim
Journal:  J Clin Immunol       Date:  2018-11-24       Impact factor: 8.317

Review 4.  CMV in Hematopoietic Stem Cell Transplantation.

Authors:  Rafael de la Cámara
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-06-20       Impact factor: 2.576

5.  Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.

Authors:  Bianca E Gama; Vanessa E Emmel; Michelle Oliveira-Silva; Luciana M Gutiyama; Leonardo Arcuri; Marta Colares; Rita de Cássia Tavares; Luis F Bouzas; Eliana Abdelhay; Rocio Hassan
Journal:  Transplant Direct       Date:  2017-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.